Not Medicare Enrolled

Dr. Penny Chow, MD

Psychiatry · Sugar Land, TX
52 SUGAR CREEK CENTER BLVD STE 225, Sugar Land, TX 77478
2814946222
Registered in NPPES since 2007
NPI: 1336270107 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chow? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chow

Dr. Penny Chow is a psychiatry specialist in Sugar Land, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Chow received a total of $6,601 from 30 pharmaceutical and/or device companies across 314 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chow is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $6,601 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,601
Total received (2018-2024)
Avg $943/year across 7 years
Top 10% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
314
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$562
2023
$865
2022
$672
2021
$884
2020
$985
2019
$1,436
2018
$1,196

Payments by company (2024)

ABBVIE INC.
$250
Bausch Health US, LLC
$79
Axsome Therapeutics, Inc.
$52
Vanda Pharmaceuticals Inc.
$45
Janssen Pharmaceuticals, Inc
$39
Otsuka America Pharmaceutical, Inc.
$35
Corium, LLC
$33
Noven Therapeutics, LLC
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 67.8% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$643
Allergan Inc.
$618
Otsuka America Pharmaceutical, Inc.
$580
Takeda Pharmaceuticals U.S.A., Inc.
$547
ABBVIE INC.
$532
Bausch Health US, LLC
$456
Sunovion Pharmaceuticals Inc.
$424
Janssen Pharmaceuticals, Inc
$409
AbbVie Inc.
$357
Lundbeck LLC
$282
Allergan, Inc.
$277
Axsome Therapeutics, Inc.
$236
Corium, LLC
$222
JAZZ PHARMACEUTICALS INC.
$174
Avanir Pharmaceuticals, Inc.
$108
Vanda Pharmaceuticals Inc.
$98
Shire North American Group Inc
$98
Ironshore Pharmaceuticals Inc.
$78
Neurocrine Biosciences, Inc.
$75
Neos Therapeutics, LP
$74
Noven Therapeutics, LLC
$62
Indivior Inc.
$57
Alkermes, Inc.
$42
Eisai Inc.
$41
Adlon Therapeutics L.P.
$32
Tris Pharma Inc
$25
Medtronic Vascular, Inc.
$18
Jazz Pharmaceuticals Inc.
$14
Vertical Pharmaceuticals, LLC
$12
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · Dayvigo · Dyanavel XR · FANAPT · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · MYDAYIS · NUEDEXTA · Nuedexta · PERSERIS · RELEXXII · REXULTI · SEEQ · SPRAVATO · SUNOSI · Secuado · TRINTELLIX · Trintellix · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · Xelstrym
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Sugar Land?
Compare psychiatrists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
713
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chow is a psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Chow receive payments from pharmaceutical companies?
Yes. Dr. Chow received a total of $6,601 from 30 companies across 314 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Chow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Sugar Land
Browse psychiatrists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in TX
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in TX
Which TX psychiatrists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →